In 1963, Liddle et al described a disorder that looks like the features of primary aldosteronism, characterized by severe hypertension and hypokalemia but with negligible secretion of aldosterone. They theorized that this was 'a disorder in which the renal tubles transport ions with such facility that the end result simulates that of a mineralocorticoid excess'. Liddle's syndrome involves abnormal kidney function, with excess reabsorption of sodium and loss of potassium from the renal tubule, and is treated with a combination of low sodium diet and potassiumsparing diuretic drugs (e.g. amiloride). We are reporting a case of 48 years known hypertensive patient admitted with acute onset quadriparesis, ultimately diagnosed as hypokalemia due to Liddle's syndrome, treated with low sodium salt and potassium sparing diuretics-amiloride responds dramatically.
InTRoDUCTIon
Hypokalemia in a patient with hypertension almost always suggest a secondary cause of hypertension. There are few conditions associated with this syndrome of hypertension and hypokalemia. We describe a rare inte resting case of a patient with a rare syndrome of hyper tension, hypokalemia and periodic paralysis: Liddle's syndrome. Though it is an autosomal dominant disease it can present at any age with features varying from only hypertension to even hypokalemic quadriparesis. World wise about 30 cases have been reported which may be a tip of the iceberg.
Jpmer case report [1] [2] [3] [4] [5] [6] [7] Resident, 8 Professor and Head . Fasting blood sugar and postprandial sugar were: 104 mg/dl, 130 mg/dl respectively. Urea: 28 mg/dl, creatinine: 0.9 mg/dl, Na + -146 mMol/l, K + -1.1 mMol/l. Arterial blood gas analysis showed pH of 7.497 suggestive of metabolic alkalosis. Thyroid function test was normal. Potassium was replaced slowly through intravenous route. The patient recovered partially and his repeat potassium was 2.3 mMol/l on day 2 of hospital admission. Oral potassium supplement started thereafter from day 3. His plasma osmolarity was 260.7 mosm/kg and urine osmolarity was 241.08 mosm/kg. Spot urine potassium was 27.1 mMol/l. Urinary transtubular potassium gra dient (TTKG) was found to be 9.8 which was consi derably high indicating that there was urinary loss of potassium. After supplementing oral potassium 60 mMol/day for 3 days, serum potassium was measured and it was found to be 3.8 mMol/l. The patient recovered from his weakness by that time. His plasma aldosterone was measured to be 6.7 ng/dl and plasma renin activity was 1.43 ng/ml/hr in resting supine position. Ultrasonography of abdomen and contrastenhanced computer tomography of abdomen was absolutely normal without any adrenal mass lesion. Renal arte rial Doppler study revealed no renal artery stenosis. Electromyogram/Nerve Conduction Study (EMGNCS) study was normal. Magnetic resonance imaging cervical spine was done which revealed degenerative changes without any spinal canal stenosis. Patient was given a trial of spironolactone but blood pressure was persis tently on higher range. Then, we started a trial of amilo ride 5 mg twice daily for 3 days. Blood pressure norma lized after 3 days along with serum potassium level. On followup after 2 weeks of medication, without any oral potassium supplement, his serum potassium was found to be 4.05 mMol/l. His BP was 132/80 on follow up visit.
BIoCHEMICAL PARAMETERS

EnDoCRInAL PARAMETERS
DISCUSSIon
Liddle's syndrome is an autosomal dominant form of salt sensitive hypertension characterized by increased plasma volume caused by excessive salt and water reabsorption in the distal nephron, resulting in low levels of plasma renin activity and aldosterone, and increased potassium excretion, resulting in low levels of serum potassium and metabolic alkalosis.
13 Mostly present at a young age though occasionally cases may not be detected until well into adulthood. However, presentation in the 6th decade of life or later has been reported very rarely. 35 However, these patients have low renin and aldosterone levels and there is conservation of sodium and excretion of potassium in the absence of mineralocorticoid excess. Genetic studies have revealed that mutations affecting cytosolic tail of the b subunit of the epithelial sodium channel (ENaC) could lead to this disorder. 68 These mutations apparently cause constitutive activation of the epithelial sodium channel of the luminal membrane of the collecting tubule and result in excessive absorption of sodium leading to volume expansion. 9 This in turn causes hypertension, leading to inhibition of renin and aldosterone secretion. A lack of downregulation of the epithelial sodium channels despite persistent volume expansion is the basis behind the pathogenesis of this syndrome. 2 It is important to screen for this condition in patients with hypertension, hypokalemia and metabolic alkalosis, as the treatment of Liddle's syndrome differs from other forms of essential or secondary hypertension. 10 Potassium sparing diuretics, like amiloride and triamterene which directly close the sodium channels are effective in Liddle's syndrome, whereas mineralocorticoid antagonist spirono lactone is ineffective since the increase in sodium channel activity is not mediated by aldosterone in this disorder. 10 Patient with hypertension and hypokalemia in response to amiloride provided additional evidence that patient may be suffering from Liddle's syndrome, whereas spironolactone fails to control hypertension and hypokalemia.
Differential diagnosis of secondary hypertension in this case was renal artery stenosis, Cushing's syndrome, Conn's syndrome (aldosterone secreting adenoma or bila teral adrenal hyperplasia) and hyperthyroidism. All these causes were excluded sequentially by normal renal artery Doppler, computer tomography, plasma aldosterone and plasma renin activity, thyroid function test, fasting cortisol, 24 hours urinary free cortisol. There are two enzymes 11b hydroxylase and 5b reductase which is associated with 'syndrome of apparent mineralocorticoid excess (SAME)', in which deficiency of those enzymes cause inability to convert cortisol into its inactive meta bolite cortisone. 11 Eleven hydroxy cortisol metabolites act on mineralocorticoid receptor in renal tubule resul ting in sodium retention and potassium excretion with hypertension which usually responds to spironolactone.
Glycyrrhizic acid, an active component of licorice, pro duces manifestation similar to the apparent mineralo corticoid excess by suppression of 11b hydroxysteroid dehydrogenase. As the patient has absence of virilization or hypogonadism, no response to spironolactone with very good response to amiloride could exclude the syn drome of apparent mineralocorticoid excess.
In the diagnosis of weakness in a background of hyper tension, Liddle's syndrome should be consi dered in adult and elderly patient. In young patient are suspected to have Liddle's syndrome based on the pre sence of hyper tension alone, whereas diagnosis of the disease in the majority of elderly patients were based on muscle weak ness rather than hypertension in the clinical observation. 5 Liddle's syndrome is autosomal dominant disorder which may occur in the family member. 12 Patient has one son and one daughter both of them were normotensive. So, our aim of the case report is that all treating physician should suspect any patient with features of hypokalemia in a background history of hypertension after excluding other secondary causes of hypertension as Liddle's syn drome which can present even at older age, diagnosis of which is very important in treating this type of patient and prevent further deterioration by diuretics other than amiloride or triamterene.
